These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 17670847

  • 1. Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus.
    Barath S, Aleksza M, Tarr T, Sipka S, Szegedi G, Kiss E.
    Lupus; 2007; 16(7):489-96. PubMed ID: 17670847
    [Abstract] [Full Text] [Related]

  • 2. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients.
    Baráth S, Soltész P, Kiss E, Aleksza M, Zeher M, Szegedi G, Sipka S.
    Autoimmunity; 2007 Nov; 40(7):521-8. PubMed ID: 17966042
    [Abstract] [Full Text] [Related]

  • 3. Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus.
    Zhang B, Zhang X, Tang FL, Zhu LP, Liu Y, Lipsky PE.
    Ann Rheum Dis; 2008 Jul; 67(7):1037-40. PubMed ID: 18199598
    [Abstract] [Full Text] [Related]

  • 4. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.
    Lee JH, Wang LC, Lin YT, Yang YH, Lin DT, Chiang BL.
    Immunology; 2006 Feb; 117(2):280-6. PubMed ID: 16423064
    [Abstract] [Full Text] [Related]

  • 5. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
    Yan B, Ye S, Chen G, Kuang M, Shen N, Chen S.
    Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
    [Abstract] [Full Text] [Related]

  • 6. Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus.
    Venigalla RK, Tretter T, Krienke S, Max R, Eckstein V, Blank N, Fiehn C, Ho AD, Lorenz HM.
    Arthritis Rheum; 2008 Jul; 58(7):2120-30. PubMed ID: 18576316
    [Abstract] [Full Text] [Related]

  • 7. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus.
    Suen JL, Li HT, Jong YJ, Chiang BL, Yen JH.
    Immunology; 2009 Jun; 127(2):196-205. PubMed ID: 18800986
    [Abstract] [Full Text] [Related]

  • 8. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
    Kuhn A, Beissert S, Krammer PH.
    Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
    [Abstract] [Full Text] [Related]

  • 9. CD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids.
    Azab NA, Bassyouni IH, Emad Y, Abd El-Wahab GA, Hamdy G, Mashahit MA.
    Clin Immunol; 2008 May; 127(2):151-7. PubMed ID: 18299252
    [Abstract] [Full Text] [Related]

  • 10. IL-10 and TGF-beta immunoregulatory cytokines rather than natural regulatory T cells are associated with the resolution phase of Vogt-Koyanagi-Harada (VKH) syndrome.
    Commodaro AG, Peron JP, Genre J, Arslanian C, Sanches L, Muccioli C, Rizzo LV, Belfort R.
    Scand J Immunol; 2010 Jul; 72(1):31-7. PubMed ID: 20591073
    [Abstract] [Full Text] [Related]

  • 11. Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients.
    Hahn BH, Anderson M, Le E, La Cava A.
    Arthritis Rheum; 2008 Aug; 58(8):2488-97. PubMed ID: 18668553
    [Abstract] [Full Text] [Related]

  • 12. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE).
    Bonelli M, Savitskaya A, von Dalwigk K, Steiner CW, Aletaha D, Smolen JS, Scheinecker C.
    Int Immunol; 2008 Jul; 20(7):861-8. PubMed ID: 18469329
    [Abstract] [Full Text] [Related]

  • 13. The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma.
    Lee JH, Yu HH, Wang LC, Yang YH, Lin YT, Chiang BL.
    Clin Exp Immunol; 2007 Apr; 148(1):53-63. PubMed ID: 17349011
    [Abstract] [Full Text] [Related]

  • 14. Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis.
    Bonelli M, von Dalwigk K, Savitskaya A, Smolen JS, Scheinecker C.
    Ann Rheum Dis; 2008 May; 67(5):664-71. PubMed ID: 17728327
    [Abstract] [Full Text] [Related]

  • 15. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
    Amoura Z, Combadiere C, Faure S, Parizot C, Miyara M, Raphaël D, Ghillani P, Debre P, Piette JC, Gorochov G.
    Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
    [Abstract] [Full Text] [Related]

  • 16. Regulatory T cells (CD4(+)CD25(bright)FoxP3(+)) expansion in systemic sclerosis correlates with disease activity and severity.
    Slobodin G, Ahmad MS, Rosner I, Peri R, Rozenbaum M, Kessel A, Toubi E, Odeh M.
    Cell Immunol; 2010 Dec; 261(2):77-80. PubMed ID: 20096404
    [Abstract] [Full Text] [Related]

  • 17. Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus.
    Franz B, Fritzsching B, Riehl A, Oberle N, Klemke CD, Sykora J, Quick S, Stumpf C, Hartmann M, Enk A, Ruzicka T, Krammer PH, Suri-Payer E, Kuhn A.
    Arthritis Rheum; 2007 Jun; 56(6):1910-20. PubMed ID: 17530636
    [Abstract] [Full Text] [Related]

  • 18. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
    Dhir V, Singh AP, Aggarwal A, Naik S, Misra R.
    Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
    [Abstract] [Full Text] [Related]

  • 19. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
    Shen LS, Wang J, Shen DF, Yuan XL, Dong P, Li MX, Xue J, Zhang FM, Ge HL, Xu D.
    Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
    [Abstract] [Full Text] [Related]

  • 20. Role of interleukin-10 and transforming growth factor beta 1 in otitis media with effusion.
    Zhao SQ, Li J, Liu H, Zhang QG, Wang Y, Han DM.
    Chin Med J (Engl); 2009 Sep 20; 122(18):2149-54. PubMed ID: 19781301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.